Jochen Maurer

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Cancer Stem Cells

Top Venues

International journal of molecular sciences

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Harshini Muralidharan, Thomas Hansen, Anja Steinle, David Schumacher, Elmar Stickeler, Jochen Maurer
Breast Cancer Stem Cells Upregulate IRF6 in Stromal Fibroblasts to Induce Stromagenesis. Cells 13 (17) (2024)
Amelie Heesch, Lars Ortmanns, Jochen Maurer, Elmar Stickeler, Sabri E M Sahnoun, Felix Manuel Mottaghy, Agnieszka Morgenroth
The Potential of PSMA as a Vascular Target in TNBC. Cells 12 (4) (2023)
Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Jochen Maurer, Felix Manuel Mottaghy, Agnieszka Morgenroth
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14 , 230. Cancers 15 (9) (2023)
Julia Wittenborn, Eva-Marie Flasshove, Tomas Kupec, Laila Najjari, Elmar Stickeler, Jochen Maurer
A Glimmer of Hope for Patients with a T3 Transformation Zone: miRNAs Are Potential Biomarkers for Cervical Dysplasia. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Julia Wittenborn, Eva-Marie Flasshove, Tomas Kupec, Laila Najjari, Elmar Stickeler, Jochen Maurer
A Glimmer of Hope for Patients with a T3 Transformation Zone: miRNAs Are Potential Biomarkers for Cervical Dysplasia. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Amelie Heesch, Lars Ortmanns, Jochen Maurer, Elmar Stickeler, Sabri E M Sahnoun, Felix Manuel Mottaghy, Agnieszka Morgenroth
The Potential of PSMA as a Vascular Target in TNBC. Cells 12 (4) (2023)
Tomas Kupec, Andreas Bleilevens, Birgit Klein, Thomas Hansen, Laila Najjari, Julia Wittenborn, Elmar Stickeler, Jochen Maurer
Comparison of Serum and Urine as Sources of miRNA Markers for the Detection of Ovarian Cancer. Biomedicines 11 (9) (2023)
Francesca Ferraro, Anja Steinle, Harini Narasimhan, Andreas Bleilevens, Paula-Marie Stolzenberg, Till Braunschweig, Elmar Stickeler, Jochen Maurer
IRAK2 Downregulation in Triple-Negative Breast Cancer Cells Decreases Cellular Growth In Vitro and Delays Tumour Progression in Murine Models. International journal of molecular sciences 24 (3) (2023)
Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Jochen Maurer, Felix Manuel Mottaghy, Agnieszka Morgenroth
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14 , 230. Cancers 15 (9) (2023)
Francesca Ferraro, Anja Steinle, Harini Narasimhan, Andreas Bleilevens, Paula-Marie Stolzenberg, Till Braunschweig, Elmar Stickeler, Jochen Maurer
IRAK2 Downregulation in Triple-Negative Breast Cancer Cells Decreases Cellular Growth In Vitro and Delays Tumour Progression in Murine Models. International journal of molecular sciences 24 (3) (2023)
Amelie Heesch, Lars Ortmanns, Jochen Maurer, Elmar Stickeler, Sabri E M Sahnoun, Felix Manuel Mottaghy, Agnieszka Morgenroth
The Potential of PSMA as a Vascular Target in TNBC. Cells 12 (4) (2023)
Julia Wittenborn, Eva-Marie Flasshove, Tomas Kupec, Laila Najjari, Elmar Stickeler, Jochen Maurer
A Glimmer of Hope for Patients with a T3 Transformation Zone: miRNAs Are Potential Biomarkers for Cervical Dysplasia. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Francesca Ferraro, Anja Steinle, Harini Narasimhan, Andreas Bleilevens, Paula-Marie Stolzenberg, Till Braunschweig, Elmar Stickeler, Jochen Maurer
IRAK2 Downregulation in Triple-Negative Breast Cancer Cells Decreases Cellular Growth In Vitro and Delays Tumour Progression in Murine Models. International journal of molecular sciences 24 (3) (2023)
Katrin Raute, Juliane Strietz, Maria Alejandra Parigiani, Geoffroy Andrieux, Oliver S Thomas, Klaus M Kistner, Marina Zintchenko, Peter Aichele, Maike Hofmann, Houjiang Zhou, Wilfried Weber, Melanie Börries, Mahima Swamy, Jochen Maurer, Susana Minguet
Breast Cancer Stem Cell-Derived Tumors Escape from γδ T-cell Immunosurveillance In Vivo by Modulating γδ T-cell Ligands. Cancer immunology research (2023)
Francesca Ferraro, Anja Steinle, Harini Narasimhan, Andreas Bleilevens, Paula-Marie Stolzenberg, Till Braunschweig, Elmar Stickeler, Jochen Maurer
IRAK2 Downregulation in Triple-Negative Breast Cancer Cells Decreases Cellular Growth In Vitro and Delays Tumour Progression in Murine Models. International journal of molecular sciences 24 (3) (2023)
Harini Narasimhan, Francesca Ferraro, Andreas Bleilevens, Ralf Weiskirchen, Elmar Stickeler, Jochen Maurer
Tumor Necrosis Factor-α (TNFα) Stimulate Triple-Negative Breast Cancer Stem Cells to Promote Intratumoral Invasion and Neovasculogenesis in the Liver of a Xenograft Model. Biology 11 (10) (2022)
Ramya Ambur Sankaranarayanan, Jennifer Peil, Andreas T J Vogg, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Jochen Maurer, Felix Manuel Mottaghy, Agnieszka Morgenroth
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 14 (1) (2022)
Anni Laine, Srikar G Nagelli, Caroline C Farrington, Umar Butt, Anna N Cvrljevic, Julia P Vainonen, Femke M Feringa, Tove J Grönroos, Prson Gautam, Sofia Khan, Harri Jaakko Sihto, Xi Qiao, Karolina Pavic, Denise C Connolly, Pauliina Kronqvist, Laura L Elo, Jochen Maurer, Krister Wennerberg, Rene H Medema, Heikki Joensuu, Emilia Peuhu, Karin E de Visser, Goutham Narla, Jukka Westermarck
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. Cancer research 81 (16) (2021)
Juliane Strietz, Stella S Stepputtis, Marie Follo, Peter Bronsert, Elmar Stickeler, Jochen Maurer
Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity. International journal of molecular sciences 22 (4) (2021)
Michael Rose, Angela Maurer, Julia Wirtz, Andreas Bleilevens, Tanja Waldmann, Maximilian Wenz, Marie Eyll, Mirja Geelvink, Melanie Gereitzig, Nadine Rüchel, Bernd Denecke, Elke Eltze, Edwin Herrmann, Marieta Toma, David Horst, Tobias Grimm, Stefan Denzinger, Thorsten Ecke, Thomas Alexander Vögeli, Ruth Knuechel, Jochen Maurer, Nadine Therese Gaisa
EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer. Oncogene 39 (44) (2020)
Sonam Dhamija, Chul Min Yang, Jeanette Seiler, Ksenia Myacheva, Maïwen Caudron-Herger, Angela Wieland, Mahmoud Abdelkarim, Yogita Sharma, Marisa Riester, Matthias Groß, Jochen Maurer, Sven Diederichs
A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradation. Nature cell biology 22 (8) (2020)
Michael Rose, Angela Maurer, Julia Wirtz, Andreas Bleilevens, Tanja Waldmann, Maximilian Wenz, Marie Eyll, Mirja Geelvink, Melanie Gereitzig, Nadine Rüchel, Bernd Denecke, Elke Eltze, Edwin Herrmann, Marieta Toma, David Horst, Tobias Grimm, Stefan Denzinger, Thorsten Ecke, Thomas Alexander Vögeli, Ruth Knuechel, Jochen Maurer, Nadine Therese Gaisa
Correction: EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer. Oncogene (2020)
Eric Metzger, Sheng Wang, Sylvia Urban, Dominica Willmann, Andreas Schmidt, Anne Offermann, Anita Allen, Manuela Sum, Nadine Obier, Félicie Cottard, Svenja Ulferts, Bogdan-Tiberius Preca, Bianca Hermann, Jochen Maurer, Holger Greschik, Veit Hornung, Oliver Einsle, Sven Perner, Axel Imhof, Manfred Jung, Roland Schuele
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells. Nature structural & molecular biology 26 (5) (2019)
Mohit Kumar Jolly, Bogdan-Tiberius Preca, Satyendra Chandra Tripathi, Dongya Jia, Jason T George, Samir M Hanash, Thomas Brabletz, Marc P Stemmler, Jochen Maurer, Herbert Levine
Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer. APL bioengineering 2 (3) (2018)